Ionis Pharmaceuticals, Inc. (IONS)
43.54
-0.46
(-1.05%)
USD |
NASDAQ |
Oct 02, 16:00
43.60
+0.06
(+0.14%)
After-Hours: 20:00
Ionis Pharmaceuticals EPS Diluted (Quarterly) : -0.6931 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6931 |
| March 31, 2026 | -0.5612 |
| December 31, 2025 | -1.414 |
| September 30, 2025 | -0.805 |
| June 30, 2025 | 0.6776 |
| March 31, 2025 | -0.9257 |
| December 31, 2024 | -0.6582 |
| September 30, 2024 | -0.9454 |
| June 30, 2024 | -0.454 |
| March 31, 2024 | -0.9812 |
| December 31, 2023 | -0.0625 |
| September 30, 2023 | -1.029 |
| June 30, 2023 | -0.596 |
| March 31, 2023 | -0.871 |
| December 31, 2022 | -0.3662 |
| September 30, 2022 | -0.331 |
| June 30, 2022 | -0.7415 |
| March 31, 2022 | -0.4602 |
| December 31, 2021 | 1.404 |
| September 30, 2021 | -0.5843 |
| June 30, 2021 | -0.5737 |
| March 31, 2021 | -0.6384 |
| December 31, 2020 | -2.536 |
| September 30, 2020 | -0.1751 |
| June 30, 2020 | -0.184 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2842 |
| December 31, 2019 | 1.201 |
| September 30, 2019 | 0.1824 |
| June 30, 2019 | -0.0066 |
| March 31, 2019 | 0.6185 |
| December 31, 2018 | 2.205 |
| September 30, 2018 | -0.0318 |
| June 30, 2018 | -0.3136 |
| March 31, 2018 | -0.0113 |
| December 31, 2017 | 0.0198 |
| September 30, 2017 | -0.021 |
| June 30, 2017 | -0.02 |
| March 31, 2017 | 0.0717 |
| December 31, 2016 | 0.21 |
| September 30, 2016 | 0.06 |
| June 30, 2016 | -0.47 |
| March 31, 2016 | -0.52 |
| December 31, 2015 | -0.59 |
| September 30, 2015 | -0.30 |
| June 30, 2015 | 0.29 |
| March 31, 2015 | -0.14 |
| December 31, 2014 | 0.25 |
| September 30, 2014 | -0.23 |
| June 30, 2014 | -0.10 |
| March 31, 2014 | -0.27 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Biogen, Inc. | 0.6557 |
| BridgeBio Pharma, Inc. | -0.7775 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| Pfizer Inc. | -0.0435 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -114.65M |
| Revenue (Quarterly) | 267.95M |
| Total Expenses (Quarterly) | 382.60M |
| Enterprise Value | 7.346B |
| Gross Profit Margin (Quarterly) | 96.13% |
| Profit Margin (Quarterly) | -42.79% |
| Earnings Yield | -7.98% |
| Normalized Earnings Yield | -8.406 |